Skip to main content
Erschienen in: Pathology & Oncology Research 3/2015

01.07.2015 | Research

The Role of MRI in the Assessment of the Local Status of Anal Carcinomas and in Their Management

verfasst von: É. Jederán, J. Lővey, Z. Szentirmai, E. Hitre, G. Léránt, K. Horváth, M. Gődény

Erschienen in: Pathology & Oncology Research | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

This study aims to define the role of Magnetic Resonance (MR) examinations in the assessment and therapy of anal cancer (AC), and to present the main features of the MR examinations and the typical tumor spread pattern. The MR examinations of 67 anal cancer patients with histologically confirmed planocellular cancer were analyzed retrospectively. The tumor size and the signal intensity, the nodal status were examined before and after the treatment, and in recidive tumors (N = 13). At the time of the diagnosis the primary tumor was in early stage (Tis, T1, T2) in 71.5 % of the cases, and it was localized in 97 %. In 97.4 % of the cases the tumor had relatively increased signal intensities compared to the adjacent muscles. Patients received chemo-radiotherapy (CRT). After CRT in 26 out of 39 patients (66.7 %) the size of the tumor decreased (in 75 %), and the signal intensity decreased on the T2 weighted (T2w) images. In the residual tumor cases (19/39) verified 6 patients out of 19 had further decrease in size, and signal intensity a year after the end of the therapy. The MR examination plays a key role in the therapy of AC, by assessing the precise local status, the possible recidive tumors, and monitoring the therapy.
Literatur
1.
Zurück zum Zitat Clark MA, Hartley A, Geh JI (2004) Cancer of the anal canal. Lancet Oncol 3:149–157CrossRef Clark MA, Hartley A, Geh JI (2004) Cancer of the anal canal. Lancet Oncol 3:149–157CrossRef
2.
Zurück zum Zitat Deans GT, McAleer JJ, Spence RA (1994) Malignant anal tumours. Br J Surg 4:500–508CrossRef Deans GT, McAleer JJ, Spence RA (1994) Malignant anal tumours. Br J Surg 4:500–508CrossRef
3.
Zurück zum Zitat Licitra L, Spinazzé S, Doci R, Evans TR, Tanum G, Ducreux M (2002) Cancer of the anal region. Crit Rev Oncol Hematol 1:77–92CrossRef Licitra L, Spinazzé S, Doci R, Evans TR, Tanum G, Ducreux M (2002) Cancer of the anal region. Crit Rev Oncol Hematol 1:77–92CrossRef
4.
Zurück zum Zitat Kásler M (ed) (2011) Az onkológia alapjai. Medicina Könyvkiadó Rt, Budapest Kásler M (ed) (2011) Az onkológia alapjai. Medicina Könyvkiadó Rt, Budapest
5.
Zurück zum Zitat Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ (1997) Anal canal and perianal epidermoid cancers. J Am Coll Surg 5:494–505CrossRef Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ (1997) Anal canal and perianal epidermoid cancers. J Am Coll Surg 5:494–505CrossRef
6.
Zurück zum Zitat Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2:270–280CrossRef Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2:270–280CrossRef
7.
Zurück zum Zitat Ries LAG, Harkins D, Krapcho M et al (eds) (2005) SEER Cancer Statistics Review, 1975–2003. National Cancer Institute, Baltimore, pp 1–103 Ries LAG, Harkins D, Krapcho M et al (eds) (2005) SEER Cancer Statistics Review, 1975–2003. National Cancer Institute, Baltimore, pp 1–103
8.
Zurück zum Zitat Stoker J (ed) (2010) Magnetic resonance imaging of the gastrointestinal tract. Springer Verlag, Berlin, Germany Stoker J (ed) (2010) Magnetic resonance imaging of the gastrointestinal tract. Springer Verlag, Berlin, Germany
9.
Zurück zum Zitat Ryan DP, Mayer RJ (2000) Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol 4:345–352CrossRef Ryan DP, Mayer RJ (2000) Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol 4:345–352CrossRef
10.
Zurück zum Zitat Glynne-Jones R, Northover J, Oliveira J, ESMO Guidelines Working Group (2009) Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):57–60. doi:10.1093/annonc/mdp129 PubMed Glynne-Jones R, Northover J, Oliveira J, ESMO Guidelines Working Group (2009) Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):57–60. doi:10.​1093/​annonc/​mdp129 PubMed
11.
Zurück zum Zitat Glynne-Jones R, Northover JM, Cervantes A, ESMO Guidelines Working Group (2010) Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v87–v92. doi:10.1093/annonc/mdq171 CrossRefPubMed Glynne-Jones R, Northover JM, Cervantes A, ESMO Guidelines Working Group (2010) Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v87–v92. doi:10.​1093/​annonc/​mdq171 CrossRefPubMed
12.
13.
Zurück zum Zitat Parikh J, Shaw A, Grant LA, Schizas AM, Datta V, Williams AB, Griffin N (2011) Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up. Eur Radiol 4:776–785. doi:10.1007/s00330-010-1980-7 CrossRef Parikh J, Shaw A, Grant LA, Schizas AM, Datta V, Williams AB, Griffin N (2011) Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up. Eur Radiol 4:776–785. doi:10.​1007/​s00330-010-1980-7 CrossRef
14.
Zurück zum Zitat Otto SD, Lee L, Buhr HJ, Frericks B, Höcht S, Kroesen AJ (2009) Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging. J Gastrointest Surg 7:1292–1298. doi:10.1007/s11605-009-0870-2 CrossRef Otto SD, Lee L, Buhr HJ, Frericks B, Höcht S, Kroesen AJ (2009) Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging. J Gastrointest Surg 7:1292–1298. doi:10.​1007/​s11605-009-0870-2 CrossRef
15.
Zurück zum Zitat Koh DM, Dzik-Jurasz A, O’Neill B, Tait D, Husband JE, Brown G (2008) Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. Br J Radiol 962:91–98. doi:10.1259/bjr/96187638 CrossRef Koh DM, Dzik-Jurasz A, O’Neill B, Tait D, Husband JE, Brown G (2008) Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. Br J Radiol 962:91–98. doi:10.​1259/​bjr/​96187638 CrossRef
18.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual (ed 7th Edition). Springer, New York Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual (ed 7th Edition). Springer, New York
19.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C (Eds) (2010) TNM Classification of Malignant Tumours (Uicc International Union Against Cancer) (7th Edition) Sobin LH, Gospodarowicz MK, Wittekind C (Eds) (2010) TNM Classification of Malignant Tumours (Uicc International Union Against Cancer) (7th Edition)
20.
Zurück zum Zitat Goldman S, Auer G, Erhardt K, Seligson U (1987) Prognostic significance of clinical stage, histologic grade, and nuclear DNA content in squamous-cell carcinoma of the anus. Dis Colon Rectum 6:444–448CrossRef Goldman S, Auer G, Erhardt K, Seligson U (1987) Prognostic significance of clinical stage, histologic grade, and nuclear DNA content in squamous-cell carcinoma of the anus. Dis Colon Rectum 6:444–448CrossRef
21.
Zurück zum Zitat Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK (2008) Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 2:147–153. doi:10.1007/s10350-007-9125-z CrossRef Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK (2008) Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 2:147–153. doi:10.​1007/​s10350-007-9125-z CrossRef
22.
Zurück zum Zitat Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH (2007) Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 3:794–800CrossRef Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH (2007) Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 3:794–800CrossRef
23.
Zurück zum Zitat Glynne-Jones R, Meadows H, Wan S, Gollins S, Leslie M, Levine E, McDonald AC, Myint S, Samuel L, Sebag-Montefiore D, National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group (2008) EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 1:119–126. doi:10.1016/j.ijrobp.2007.12.012 CrossRef Glynne-Jones R, Meadows H, Wan S, Gollins S, Leslie M, Levine E, McDonald AC, Myint S, Samuel L, Sebag-Montefiore D, National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group (2008) EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 1:119–126. doi:10.​1016/​j.​ijrobp.​2007.​12.​012 CrossRef
24.
Zurück zum Zitat Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 5:2040–2049 Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 5:2040–2049
25.
Zurück zum Zitat UK Co-ordinating Committee on Cancer Research (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. Lancet 9034:1049–1054 UK Co-ordinating Committee on Cancer Research (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. Lancet 9034:1049–1054
26.
Zurück zum Zitat Touboul E, Schlienger M, Buffat L, Lefkopoulos D, Pène F, Parc R, Tiret E, Gallot D, Malafosse M, Laugier A (1994) Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 6:1569–1579CrossRef Touboul E, Schlienger M, Buffat L, Lefkopoulos D, Pène F, Parc R, Tiret E, Gallot D, Malafosse M, Laugier A (1994) Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 6:1569–1579CrossRef
27.
Zurück zum Zitat Schlienger M, Krzisch C, Pene F, Marin JL, Gindrey-Vie B, Mauban S, Barthelemy N, Habrand JL, Socie G, Parc R et al (1989) Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases. Int J Radiat Oncol Biol Phys 6:1141–1151CrossRef Schlienger M, Krzisch C, Pene F, Marin JL, Gindrey-Vie B, Mauban S, Barthelemy N, Habrand JL, Socie G, Parc R et al (1989) Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases. Int J Radiat Oncol Biol Phys 6:1141–1151CrossRef
28.
Zurück zum Zitat Myerson RJ, Kong F, Birnbaum EH, Fleshman JW, Kodner IJ, Picus J, Ratkin GA, Read TE, Walz BJ (2001) Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 1:15–22CrossRef Myerson RJ, Kong F, Birnbaum EH, Fleshman JW, Kodner IJ, Picus J, Ratkin GA, Read TE, Walz BJ (2001) Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 1:15–22CrossRef
29.
Zurück zum Zitat Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF (1997) Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 3:651–657CrossRef Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF (1997) Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 3:651–657CrossRef
30.
Zurück zum Zitat Klas JV, Rothenberger DA, Wong WD, Madoff RD (1999) Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 8:1686–1693CrossRef Klas JV, Rothenberger DA, Wong WD, Madoff RD (1999) Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 8:1686–1693CrossRef
31.
Zurück zum Zitat Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet JM, Mornex F (1998) Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 3:249–256CrossRef Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet JM, Mornex F (1998) Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 3:249–256CrossRef
32.
Zurück zum Zitat Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, Williams GT (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2:371–377CrossRef Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, Williams GT (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2:371–377CrossRef
33.
Zurück zum Zitat Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P (2005) Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 5:1316–1324CrossRef Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P (2005) Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 5:1316–1324CrossRef
34.
Zurück zum Zitat Goh V, Gollub FK, Liaw J, Wellsted D, Przybytniak I, Padhani AR, Glynne-Jones R (2010) Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome? Int J Radiat Oncol Biol Phys 3:715–721. doi:10.1016/j.ijrobp.2009.08.055, Epub 2010 Feb 18CrossRef Goh V, Gollub FK, Liaw J, Wellsted D, Przybytniak I, Padhani AR, Glynne-Jones R (2010) Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome? Int J Radiat Oncol Biol Phys 3:715–721. doi:10.​1016/​j.​ijrobp.​2009.​08.​055, Epub 2010 Feb 18CrossRef
35.
Zurück zum Zitat Roach SC, Hulse PA, Moulding FJ, Wilson R, Carrington BM (2005) Magnetic resonance imaging of anal cancer. Clin Radiol 10:1111–1119CrossRef Roach SC, Hulse PA, Moulding FJ, Wilson R, Carrington BM (2005) Magnetic resonance imaging of anal cancer. Clin Radiol 10:1111–1119CrossRef
Metadaten
Titel
The Role of MRI in the Assessment of the Local Status of Anal Carcinomas and in Their Management
verfasst von
É. Jederán
J. Lővey
Z. Szentirmai
E. Hitre
G. Léránt
K. Horváth
M. Gődény
Publikationsdatum
01.07.2015
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 3/2015
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-014-9857-8

Weitere Artikel der Ausgabe 3/2015

Pathology & Oncology Research 3/2015 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.